Pharmaceuticals, Healthcare & Biotechnology

The Turkish pharmaceuticals and healthcare sector is continuing to attract foreign investors, following ongoing regulatory reform, modernisation and restructuring. The potential for returns is excellent with forecasts of high growth and an expanding product market as Turkish consumers adopt a more sophisticated approach to healthcare. Turkish groups divesting their pharma enterprises, international healthcare providers groups establishing ventures in the private sector and global manufacturers entering and re-entering the market will ensure this sector remains in the spotlight for the years ahead.

 

Team Leaders     Yegân Liaje   Corporate/M&A
  Fethi Pekin Corporate/M&A